Study of INV-102 Ophthalmic Solution in Adults With Moderate to Severe Dry Eye Disease
Status:
COMPLETED
Trial end date:
2024-07-03
Target enrollment:
Participant gender:
Summary
Phase 2 study to assess the efficacy of topically administered eyedrops of INV-102 during 4-week repeat dosing in subjects with moderate to severe dry eye disease.